Among adults with an overweight or obesity diagnosis, GLP-1 prescribing increased 586.7% between 2019 and 2024 according to FAIR Health data
Lilly's 2025 guidance of USD 5861 billion implies continued 32% growth momentum, validated by the SURMOUNT-5 Phase 3b head-to-head trial result: Zepbound demonstrated 47% greater relative weight loss compared to Wegovy the most commercially consequential head-to-head data in the obesity market
In 2023, its first full year on the market, Mounjaro brought in nearly $5.2 billion
This explains why, in practice, some people prefer it over classic L-carnitine when looking for an 'acetyl donor' , beyond the usual nutritional use of base carnitine
The rubber stopper should not be removed, and the vial should only be accessed using appropriate sterile technique with sterile needles and syringes
Whether youre struggling with fatigue, low energy, or just want to boost your vitality, his expert guidance will help you achieve optimal results